Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial

Kebir, SiedSiedKebirSchaub, ChristinaChristinaSchaubJunold, NinaNinaJunoldHattingen, ElkeElkeHattingenSchäfer, NiklasNiklasSchäferSteinbach, Joachim P.Joachim P.SteinbachWeyerbrock, AstridAstridWeyerbrockHau, PeterPeterHauGoldbrunner, RolandRolandGoldbrunnerGalldiks, NorbertNorbertGalldiksWeller, JohannesJohannesWellerMack, FredericFredericMackTzaridis, TheophilosTheophilosTzaridisBähr, OliverOliverBährSeidel, ClemensClemensSeidelSchlegel, UweUweSchlegelSchmidt-Graf, FriederikeFriederikeSchmidt-GrafRohde, VeitVeitRohdeBorchers, ChristianChristianBorchersTabatabai, GhazalehGhazalehTabatabaiHänel, MathiasMathiasHänelSabel, MichaelMichaelSabelGerlach, RüdigerRüdigerGerlachKrex, DietmarDietmarKrexBelka, ClausClausBelkaVatter, HartmutHartmutVatterProescholdt, MartinMartinProescholdtGlas, MartinMartinGlasHerrlinger, UlrichUlrichHerrlinger2020-12-102020-12-1020190167-594Xhttps://resolver.sub.uni-goettingen.de/purl?gro-2/71188enBaseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trialjournal_article10.1007/s11060-019-03246-41573-7373